Top
IFRD2 has not been detected as a mutational cancer driver

IFRD2
Ensembl id ENSG00000214706
Mutated samples
Coding Sequence 69 (1.0%)
Protein Affecting 20 (0.3%)
Mode of action Unclassified
Known driver No
Cancer type Signals (Biases)
Clust Clustered Mutations FM Functional Mutations Rec Recurrent Mutations
This plot shows the most recurrently mutated cancer types in all IFRD2 gene mutations. Each bar of the histogram indicates the amount of samples with PAMs.

Cancer type Driver Mutated samples (CS) Mutated samples (PAM) % Mutated samples (PAM)
Breast carcinoma No 4 3 0.26
Cutaneous melanoma No 16 3 0.81
Head and neck squamous cell carcinoma No 6 3 0.80
Lung adenocarcinoma No 7 2 0.51
Bladder carcinoma No 5 2 2.04
Esophageal carcinoma No 2 2 1.37
Uterine corpus endometrioid carcinoma No 6 1 0.43
Chronic lymphocytic leukemia No 2 1 0.34
Serous ovarian adenocarcinoma No 5 1 0.32
Colorectal adenocarcinoma No 1 1 0.44
Glioblastoma multiforme No 2 1 0.26
Prostate adenocarcinoma No 2 0 0.00
Lung squamous cell carcinoma No 4 0 0.00
Renal clear cell carcinoma No 2 0 0.00
Lower grade glioma No 1 0 0.00
Stomach adenocarcinoma No 4 0 0.00
The mutations needle plot shows the distribution of the observed cancer mutations along the protein sequence and it's possible mutational clusters and hotspots. The needles' height and head size represent mutational recurrence. Needles of different categories that fall in the same amino acid residues are stacked.

Variant Locus Samples AA pos AA change Consequence